# Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas

> **NCT00076102** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 36 (actual)

## Conditions studied

- Neurofibromatosis 1
- Neurofibroma, Plexiform

## Interventions

- **DRUG:** Pirfenidone

## Key facts

- **NCT ID:** NCT00076102
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07-21
- **Primary completion:** 2010-04-01
- **Final completion:** 2010-04-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2018-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00076102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00076102, "Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00076102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*